Lonigutamab (Anti-IGF1R / CD221)Lonigutamab (Anti-IGF1R / CD221)
Move your mouse over image or click to enlarge

Lonigutamab (Anti-IGF1R / CD221)

Lonigutamab (hz208F2-4) is a humanized monoclonal antibody against the insulin-like growth factor-1 receptor (IGF-1R) with the potential to treat thyroid eye disease (TED). MW: 146.26 KD.
Cat# Size Price Qty Buy
A2926-1mg*25 1mg*25
£4,152.00
A2926-1mg*5 1mg*5
£1,384.00
A2926-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2926

Related Documents